213 related articles for article (PubMed ID: 16406404)
1. Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation.
Goyal AK; Rawat A; Mahor S; Gupta PN; Khatri K; Vyas SP
Int J Pharm; 2006 Feb; 309(1-2):227-33. PubMed ID: 16406404
[TBL] [Abstract][Full Text] [Related]
2. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
Shukla A; Katare OP; Singh B; Vyas SP
Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
[TBL] [Abstract][Full Text] [Related]
5. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
6. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
7. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
8. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
9. Immune response induced by a different combined immunization of HBsAg vaccine.
Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
[TBL] [Abstract][Full Text] [Related]
10. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
11. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
Mishra D; Dubey V; Asthana A; Saraf DK; Jain NK
Vaccine; 2006 May; 24(22):4847-55. PubMed ID: 16600441
[TBL] [Abstract][Full Text] [Related]
12. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
[TBL] [Abstract][Full Text] [Related]
13. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA.
Shen E; Li L; Li L; Feng L; Lu L; Yao Z; Lin H; Wu C
Cell Mol Immunol; 2007 Apr; 4(2):113-20. PubMed ID: 17484805
[TBL] [Abstract][Full Text] [Related]
14. Viral protein complexed liposomes for intranasal delivery of hepatitis B surface antigen.
Tiwari S; Verma SK; Agrawal GP; Vyas SP
Int J Pharm; 2011 Jul; 413(1-2):211-9. PubMed ID: 21540094
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
[TBL] [Abstract][Full Text] [Related]
19. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
[TBL] [Abstract][Full Text] [Related]
20. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]